Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab

NCT00379431 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00379431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00379431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
November 27, 2006
Completion date
February 2, 2009
Enrollment
9 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

early and severe systemic sclerosis